Literature DB >> 26024288

Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.

Neil R McIntyre1, Edward W Lowe1, Matthew R Battistini2, James W Leahy2,3, David J Merkler2.   

Abstract

Peptidylglycine α-amidating monooxygenase (PAM) is a bifunctional enzyme that catalyzes the final reaction in the maturation of α-amidated peptide hormones. Peptidylglycine α-hydroxylating monooxygenase (PHM) is the PAM domain responsible for the copper-, ascorbate- and O2-dependent hydroxylation of a glycine-extended peptide. Peptidylamidoglycolate lyase is the PAM domain responsible for the Zn(II)-dependent dealkylation of the α-hydroxyglycine-containing precursor to the final α-amidated peptide. We report herein that cinnamic acid and cinnamic acid analogs are inhibitors or inactivators of PHM. The inactivation chemistry exhibited by the cinnamates exhibits all the attributes of a suicide-substrate. However, we find no evidence for the formation of an irreversible linkage between cinnamate and PHM in the inactivated enzyme. Our data support the reversible formation of a Michael adduct between an active site nucleophile and cinnamate that leads to inactive enzyme. Our data are of significance given that cinnamates are found in foods, perfumes, cosmetics and pharmaceuticals.

Entities:  

Keywords:  Cinnamate; cinnamate–Cu(I) complex; peptidylglycine α-hydroxylating monooxygenase; time-dependent enzyme inactivation

Mesh:

Substances:

Year:  2015        PMID: 26024288      PMCID: PMC4801743          DOI: 10.3109/14756366.2015.1046064

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  60 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Alternative mRNA splicing generates multiple forms of peptidyl-glycine alpha-amidating monooxygenase in rat atrium.

Authors:  D A Stoffers; C B Green; B A Eipper
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Multiple forms of peptidyl alpha-amidating enzyme: purification from rat medullary thyroid carcinoma CA-77 cell-conditioned medium.

Authors:  J P Gilligan; S J Lovato; N M Mehta; A H Bertelsen; A Y Jeng; P P Tamburini
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

Review 4.  Peptide alpha-amidation.

Authors:  B A Eipper; R E Mains
Journal:  Annu Rev Physiol       Date:  1988       Impact factor: 19.318

5.  Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.

Authors:  P Rocchi; F Boudouresque; A J Zamora; X Muracciole; E Lechevallier; P M Martin; L Ouafik
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  Peptidylglycine-alpha-hydroxylating monooxygenase generates two hydroxylated products from its mechanism-based suicide substrate, 4-phenyl-3-butenoic acid.

Authors:  W J Driscoll; S König; H M Fales; L K Pannell; B A Eipper; G P Mueller
Journal:  Biochemistry       Date:  2000-07-11       Impact factor: 3.162

7.  Neuropeptide amidation: cloning of a bifunctional alpha-amidating enzyme from Aplysia.

Authors:  X Fan; S Spijker; D B Akalal; G T Nagle
Journal:  Brain Res Mol Brain Res       Date:  2000-10-20

8.  Characterization of a peptide alpha-amidation activity in human plasma and tissues.

Authors:  G S Wand; R L Ney; S Baylin; B Eipper; R E Mains
Journal:  Metabolism       Date:  1985-11       Impact factor: 8.694

9.  Olefin oxygenation and N-dealkylation by dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.

Authors:  S R Padgette; K Wimalasena; H H Herman; S R Sirimanne; S W May
Journal:  Biochemistry       Date:  1985-10-08       Impact factor: 3.162

10.  Alzheimer's disease: low levels of peptide alpha-amidation activity in brain and CSF.

Authors:  G S Wand; C May; V May; P J Whitehouse; S I Rapoport; B A Eipper
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

View more
  1 in total

Review 1.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.